We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$683M
AUM Growth
+$58.2M
(+9.3%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.97M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
BCPC
Balchem Corp
BCPC
|
+$2.09M |
| 4 |
Quest Diagnostics
DGX
|
+$1.56M |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.54M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.95M |
| 3 |
Comcast
CMCSA
|
+$1.76M |
| 4 |
CDW
CDW
|
+$1.48M |
| 5 |
Medtronic
MDT
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $41.7M | 6.1% |
83,780
-638
| -0.8% | -$277K |
|
|
DFAI
2
Dimensional International Core Equity Market ETF
DFAI
$17.4B
| $41.6M | 6.1% |
1,204,753
+39,194
| +3% | +$1.28M |
|
3
NVIDIA
NVDA
$4.86T
| $35.1M | 5.14% |
222,144
+1,828
| +0.8% | +$230K |
|
4
Apple
AAPL
$4.54T
| $34.2M | 5.01% |
166,834
-307
| -0.2% | -$62K |
|
5
Amazon
AMZN
$2.92T
| $19.8M | 2.89% |
90,080
+1,022
| +1% | +$202K |
|
6
JPMorgan Chase
JPM
$935B
| $17.3M | 2.53% |
59,644
+230
| +0.4% | +$58.7K |
|
7
Meta Platforms (Facebook)
META
$1.42T
| $17.2M | 2.51% |
23,240
+339
| +1% | +$209K |
|
8
Alphabet (Google) Class C
GOOG
$4.36T
| $15.9M | 2.33% |
89,697
-3,420
| -4% | -$565K |
|
9
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
| $12.3M | 1.8% |
215,641
-3,254
| -1% | -$180K |
|
10
Berkshire Hathaway Class A
BRK.A
$1.1T
| $11.7M | 1.71% |
16
| – | – |
|
11
Abbott
ABT
$183B
| $8.75M | 1.28% |
64,366
-1,263
| -2% | -$167K |
|
12
Eli Lilly
LLY
$1.02T
| $7.9M | 1.16% |
10,129
+158
| +2% | +$123K |
|
13
Mastercard
MA
$502B
| $7.74M | 1.13% |
13,773
+89
| +0.7% | +$49.2K |
|
14
Costco
COST
$422B
| $7.13M | 1.04% |
7,203
+152
| +2% | +$151K |
|
15
NextEra Energy
NEE
$181B
| $6.75M | 0.99% |
97,270
+1,792
| +2% | +$124K |
|
16
RTX Corp
RTX
$290B
| $6.23M | 0.91% |
42,669
-296
| -0.7% | -$39.4K |
|
17
Booking.com
BKNG
$149B
| $6.1M | 0.89% |
26,325
+225
| +0.9% | +$46.1K |
|
18
Walmart Inc
WMT
$885B
| $6.03M | 0.88% |
61,691
+302
| +0.5% | +$28.8K |
|
19
Amgen
AMGN
$208B
| $5.81M | 0.85% |
20,821
+232
| +1% | +$65.7K |
|
20
Qualcomm
QCOM
$155B
| $5.76M | 0.84% |
36,165
+152
| +0.4% | +$22.4K |
|
|
21
Berkshire Hathaway Class B
BRK.B
$1.1T
| $5.72M | 0.84% |
11,781
+2,473
| +27% | +$1.26M |
|
|
22
Alphabet (Google) Class A
GOOGL
$4.36T
| $5.51M | 0.81% |
31,270
+933
| +3% | +$153K |
|
23
ExxonMobil
XOM
$644B
| $5.37M | 0.79% |
49,806
+94
| +0.2% | +$10K |
|
24
Amphenol
APH
$198B
| $5.31M | 0.78% |
53,825
-14,087
| -21% | -$1.15M |
|
25
Blackrock
BLK
$169B
| $5.31M | 0.78% |
5,061
+62
| +1% | +$58.6K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
- First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
- First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
- First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
- First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
- First National Advisers opened 14 new positions and closed 5 in Q2 2025.
- First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.
Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.